Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 3/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096842 | 0.82 | CCR2 (0.35) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL30096893 | 0.80 | SLC6A3 (0.40) | OPRL1OPRM1SLC6A3SLC6A4MAOA | |
| SCHEMBL30096889 | 0.80 | KDM1A (0.46) | OPRL1OPRM1SLC6A3SLC6A4KDM1A | |
| SCHEMBL30096836 | 0.78 | MGAT2 (0.36) | SLC6A4LMNA | |
| SCHEMBL30096902 | 0.76 | SLC6A4 (0.36) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL31504306 | 0.75 | HTR2A (0.41) | OPRL1OPRM1SLC6A3MAOAMAOB | |
| SCHEMBL30850067 | 0.74 | SLC6A4 (0.31) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL19580567 | 0.74 | SLC6A3 (0.43) | OPRL1OPRM1SLC6A3SLC6A4MAOA | |
| SCHEMBL13838853 | 0.72 | OPRL1 (0.52) | OPRL1OPRM1SLC6A3SLC6A4MAOA | |
| Ammonia Solution, Strong SCHEMBL793057 | 0.71 | OPRL1 (0.50) | OPRL1OPRM1SLC6A3SLC6A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| WO-2022196734-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK株式会社 | 2022-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | AFF1, AFF2, AFF4 | OPRL1 1134/4885OPRM1 429/4885SLC6A3 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.